Hadassah

Hadassah Pioneer Named Honorary President of International European Liver Congress

Tuesday, Mar 29 2016

Prof. Daniel Shouval, founding head of the Hadassah Medical Center’s Liver Unit.

The European Association for the Study of the Liver (EASL) has named Prof. Daniel Shouval, founding head of the Hadassah Medical Center’s Liver Unit, “Honorary President” of its International Liver Congress™ 2016. The 2016 Conference will take place in Barcelona, April 13-17, with more than 10,000 researchers and physicians from five continents.

EASL's choice expresses recognition of Prof. Shouval's contribution to the understanding and treatment of liver disease in Israel and the world, particularly his work on developing a vaccine for hepatitis B. As a result of Prof. Shouval’s work, Israel was among the first countries to endorse universal vaccination for hepatitis B, a leading cause of liver cancer and liver failure.   Today, 189 of the 194 countries belonging to the World Health Organization recommend this vaccine.

Prof. Shouval was also involved in developing a vaccine for hepatitis A. Israel became the first country to institute universal vaccination for this disease, which was very common in the region. As a result, there was a 95 percent drop in its incidence among children and young adults. The vaccines he and his team created for hepatitis A and B have virtually wiped out these diseases.

In 1983, Prof. Shouval established the first liver unit in Israel at Hadassah, which he directed for almost 30 years until his retirement in 2010. He treated thousands of patients during his   long career at Hadassah, where he was responsible for many breakthroughs, mentored generations of outstanding liver experts, and published pivotal research papers. Today, he continues to teach medicine and to advise the World Health Organization and other health bodies in Europe, Asia, and Africa.

“As someone who has devoted his life to the study of the liver," said Prof. Shouval, “I am very moved at being chosen. More than that, the honor recognizes the work of the outstanding Hadassah liver team that provides hope to patients who had no hope. Furthermore, it recognizes the contribution of the Israeli medical establishment in general, and Hadassah in particular, in finding cures for diseases that threaten such a wide population."

Related Stories

alt_text

Wednesday, Sep 30 2020

Healing the World, Together, In the New Year

In the spring of 2020, Dr. Dana Wolf, the longtime head of Hadassah's Virology Unit, took the helm of the Clinical Virology Laboratory, beginning a high-speed race to create a serum of COVID-19 antibodies.

READ MORE ›
alt_text

Friday, Sep 25 2020

Hadassah Hospital Welcomes First Baby of Jewish New Year 5781

Adel Toubul is the first baby to be born at Hadassah Hospital Ein Kerem in the Jewish New Year 5781.

READ MORE ›
alt_text

Friday, Sep 25 2020

Hadassah Explores Link Between Levels of Anxiety and Eating Sweets

How are anxiety and eating high-carbohydrate foods connected? Does everyone self-soothe with sweets or other comfort foods when they are anxious?

READ MORE ›
alt_text

Wednesday, Sep 23 2020

Hadassah’s Pollin Center Promotes Health, One Neighborhood at a Time

With a mentoring program tailored to community centers, the Hadassah Medical Organization’s Linda Joy Pollin Cardiovascular Wellness Center for Women is transforming these local spaces into health-promotion settings.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Israel Travel

israeltravel@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More